FLT3 and acute myeloid leukemia: Another study showed that stromal cells diminish the cytotoxic effect of multiple kinase inhibitors that target FLT3-mutated AML cells and the JAK inhibitors could override stromal protection to potentiate the anti-cancer activity of FLT3 inhibitors26.